Lv3
248 积分 2022-10-02 加入
Lysine-Targeted Covalent Inhibitors: Emerging Warheads and Expanding Applications in Medicinal Chemistry
5天前
已完结
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study
18天前
已完结
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
21天前
已完结
Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
21天前
已完结
Prostate cancer
21天前
已完结
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study
26天前
已完结
THE PROSTATE: DEVELOPMENT AND PHYSIOLOGY
27天前
已完结
Prostate Cancer: A Review
27天前
已完结
Prostate cancer
27天前
已完结
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
28天前
已完结
皖公网安备34019202002308
